![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide](https://www.researchgate.net/publication/363201315/figure/fig3/AS:11431281082605778@1662084799021/Efficacy-of-tirzepatide-in-phase-2-GPGB-14-and-phase-3-SURPASS-1-to-5-15-19.png)
surpass 1 tirzepatide
Shipping Estimate
surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide](https://www.researchgate.net/publication/381212710/figure/tbl3/AS:11431281251283441@1718173626979/Results-of-SURPASS-1-5-for-tirzepatide-treatment-in-T2D.png)
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide](https://www.endocrine.org/-/media/endocrine/images/journal-articles/surpass1-trial-of-tirzepatide-in-type-2-diabetes-fig-1a.jpg)
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1425010346325638)
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide](https://www.researchgate.net/publication/363739340/figure/tbl3/AS:11431281085677435@1663835861723/Incidence-of-mild-and-severe-side-effects-of-tirzepatide-in-SURPASS-1-5-clinical-trials.png)
![surpass 1 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Results of SURPASS-1-5 for tirzepatide](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-023-02344-1/MediaObjects/41591_2023_2344_Fig2_HTML.png)
